In last trading session, Summit Therapeutics Inc (NASDAQ:SMMT) saw 3.31 million shares changing hands with its beta currently measuring -1.08. Company’s recent per share price
In last trading session, Summit Therapeutics Inc (NASDAQ:SMMT) saw 1.36 million shares changing hands with its beta currently measuring -1.08. Company’s recent per share price
During the recent session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 0.38 million, with the beta value of the company hitting -1.08. The 52-week high
In today’s recent session, 0.46 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) have been traded, and its beta is -1.06. Most recently the company’s
In the last trading session, 1.76 million Summit Therapeutics Inc (NASDAQ:SMMT) shares changed hands as the company’s beta touched -1.05. With the company’s per share
In the latest trading session, 0.31 million Summit Therapeutics Inc (NASDAQ:SMMT) shares changed hands as the company’s beta touched -1.05. With the company’s most recent
In last trading session, Summit Therapeutics Inc (NASDAQ:SMMT) saw 1.85 million shares changing hands with its beta currently measuring -0.86. Company’s recent per share price
Summit Therapeutics Inc (NASDAQ:SMMT) has a beta value of -0.88 and has seen 1.73 million shares traded in the last trading session. The company, currently
During the recent session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 0.62 million, with the beta value of the company hitting -0.86. At the last
Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 2.47 million during the last session, with the company’s beta value hitting -0.87. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
